TY - JOUR
T1 - Prenatal exposure to phthalates and infant development at 6 months
T2 - Prospective mothers and children's environmental health (MOCEH) study
AU - Kim, Yeni
AU - Ha, Eun Hee
AU - Kim, Eui Jung
AU - Park, Hyesook
AU - Ha, Mina
AU - Kim, Ja Hyeong
AU - Hong, Yun Chul
AU - Chang, Namsoo
AU - Kim, Bung Nyun
PY - 2011/10
Y1 - 2011/10
N2 - Background: There are increasing concerns over adverse effects of prenatal phthalate exposure on the neurodevelopment of infants. Objectives: Our goal was to explore the association between prenatal di(2-ethylhexyl) phthalate and dibutyl phthalate exposure and the Mental and Psychomotor Developmental Indices (MDI and PDI, respectively) of the Bayley Scales of Infant Development at 6 months, as part of the Mothers and Children's Environmental Health Study. Methods: Between 2006 and 2009, 460 mother-infant pairs from Seoul, Cheonan, and Ulsan, Korea, participated. Prenatal mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono-n-butyl phthalate (MBP) were measured in one urine sample acquired from each mother during the third trimester of pregnancy. Associations with log-transformed creatinine-corrected phthalate concentrations were estimated using linear regression models adjusted for potential confounders. Results: MDI was inversely associated with the natural log concentrations (micrograms per gram creatinine) of MEHHP [β = -0.97; confidence interval (CI), -1.85 to -0.08] and MEOHP (β = -0.95; CI, -1.87 to -0.03), and PDI was inversely associated with MEHHP (β = -1.20; CI, -2.33 to -0.08). In males, MDI was inversely associated with MEHHP (β = -1.46; CI, -2.70 to -0.22), MEOHP (β = -1.57; CI, -2.87 to -0.28), and MBP (β = -0.93; CI, -1.82 to -0.05); PDI was inversely associated with MEHHP (β = -2.36; CI, -3.94 to -0.79), MEOHP (β = -2.05; CI, -3.71 to -0.39), and MBP (β = -1.25; CI, -2.40 to -0.11). No significant linear associations were observed for females. Conclusions: The results suggest that prenatal exposure to phthalates may be inversely associated with the MDI and PDI of infants, particularly males, at 6 months.
AB - Background: There are increasing concerns over adverse effects of prenatal phthalate exposure on the neurodevelopment of infants. Objectives: Our goal was to explore the association between prenatal di(2-ethylhexyl) phthalate and dibutyl phthalate exposure and the Mental and Psychomotor Developmental Indices (MDI and PDI, respectively) of the Bayley Scales of Infant Development at 6 months, as part of the Mothers and Children's Environmental Health Study. Methods: Between 2006 and 2009, 460 mother-infant pairs from Seoul, Cheonan, and Ulsan, Korea, participated. Prenatal mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono-n-butyl phthalate (MBP) were measured in one urine sample acquired from each mother during the third trimester of pregnancy. Associations with log-transformed creatinine-corrected phthalate concentrations were estimated using linear regression models adjusted for potential confounders. Results: MDI was inversely associated with the natural log concentrations (micrograms per gram creatinine) of MEHHP [β = -0.97; confidence interval (CI), -1.85 to -0.08] and MEOHP (β = -0.95; CI, -1.87 to -0.03), and PDI was inversely associated with MEHHP (β = -1.20; CI, -2.33 to -0.08). In males, MDI was inversely associated with MEHHP (β = -1.46; CI, -2.70 to -0.22), MEOHP (β = -1.57; CI, -2.87 to -0.28), and MBP (β = -0.93; CI, -1.82 to -0.05); PDI was inversely associated with MEHHP (β = -2.36; CI, -3.94 to -0.79), MEOHP (β = -2.05; CI, -3.71 to -0.39), and MBP (β = -1.25; CI, -2.40 to -0.11). No significant linear associations were observed for females. Conclusions: The results suggest that prenatal exposure to phthalates may be inversely associated with the MDI and PDI of infants, particularly males, at 6 months.
KW - Development
KW - Di(2-ethylhexyl) phthalate
KW - Dibutyl phthalate
KW - Infant
KW - Prenatal
UR - http://www.scopus.com/inward/record.url?scp=80053460726&partnerID=8YFLogxK
U2 - 10.1289/ehp.1003178
DO - 10.1289/ehp.1003178
M3 - Article
C2 - 21737372
AN - SCOPUS:80053460726
SN - 0091-6765
VL - 119
SP - 1495
EP - 1500
JO - Environmental Health Perspectives
JF - Environmental Health Perspectives
IS - 10
ER -